Medical Countermeasures A Yeast-Brewed Flu Shot That Could Outlast the SeasonGlobal Biodefense StaffAugust 24, 2026
Medical Countermeasures Coating the Liver’s Doorways Could Make mRNA Vaccines Safer and More EffectiveGlobal Biodefense StaffAugust 24, 2026
Medical Countermeasures Scientists Map a Weak Spot on Crimean-Congo Hemorrhagic Fever Virus That Antibodies Can ExploitGlobal Biodefense StaffAugust 23, 2026
FDA Approves Ridgeback Biotherapeutics to Begin Human Testing of Potential Treatment for COVID-19 Medical Countermeasures April 7, 2020 …
INOVIO Initiates Phase 1 Clinical Trial of COVID-19 Vaccine Candidate Medical Countermeasures April 7, 2020 …
BARDA and Genentech to Accelerate Phase 3 Clinical Trial of a Novel COVID-19 Therapeutic Treatment Industry News April 6, 2020 …
Amgen and Adaptive Biotechnologies Announce Collaboration to Develop a Therapeutic to Prevent or Treat COVID-19 Medical Countermeasures April 2, 2020 …
Emergent BioSolutions Partners with BARDA to Expedite Development of Plasma-Derived Therapy for COVID-19 Medical Countermeasures April 2, 2020 …
Celularity Announces FDA Clearance of IND Application for CYNK-001 in Coronavirus, First in Cellular Therapy Medical Countermeasures April 2, 2020 …
Tests in Engineered Human Tissues Show hrsACE2 Drug Blocked Early Stages of SARS-CoV-2 Infection Medical Countermeasures April 2, 2020 …
Hydroxychloroquine and Azythromycine Combo Treatment for COVID Can Raise Risk for Dangerous Abnormal Heart Rhythms Medical Countermeasures April 2, 2020 …
JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic Medical Countermeasures April 1, 2020 …
Sanofi and Translate Bio Team Up to Develop Novel Coronavirus mRNA Vaccine Medical Countermeasures March 28, 2020 …
Mapping Risks to the Drug Supply Chain During COVID-19 Pandemic: Critical Shortages Likely in U.S. Medical Countermeasures March 28, 2020 …
5 Questions Answered About Chloroquine: An Unproven Drug Against Coronavirus Medical Countermeasures March 25, 2020 …
WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment Medical Countermeasures March 25, 2020 …
FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients Medical Countermeasures March 24, 2020 …
Why Don’t We Have Drugs to Treat COVID-19 and How Long Will It Take to Develop Them? Medical Countermeasures March 21, 2020 …
Ridgeback Biotherapeutics and DRIVE Partner to Develop Clinical Stage Coronavirus Treatment Medical Countermeasures March 19, 2020 …
Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19 Medical Countermeasures March 18, 2020 …
